Loading clinical trials...
Loading clinical trials...
An Open-Label, Randomized, Adaptive, Two-Arm, Multicenter Trial to Evaluate Pharmacokinetics And Pharmacodynamics of Two Doses of Oseltamivir (Tamiflu®) in The Treatment Of Influenza in Immunocompromised Children Less Than 13 Years Of Age, With Confirmed Influenza Infection
Conditions
Interventions
Oseltamivir
Locations
50
United States
Lucile Packard Child Hosp; Pediatric Pulmonary Division
Palo Alto, California, United States
The Children's Hospital; Pediatric Infectious Diseases
Aurora, Colorado, United States
Tufts Medical Center
Boston, Massachusetts, United States
University of Minnesota
Minneapolis, Minnesota, United States
SUNY Upstate Medical University
Syracuse, New York, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
Start Date
January 22, 2014
Primary Completion Date
June 17, 2018
Completion Date
June 17, 2018
Last Updated
October 16, 2018
NCT07291635
NCT06094010
NCT06417762
NCT06160128
NCT07396428
NCT07310472
Lead Sponsor
Hoffmann-La Roche
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions